Novo Nordisk A/S (NVO)

Last Closing Price: 37.45 (2026-02-27)

Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Novo Nordisk A/S (NVO) had Revenue of $46.79B for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
Revenue
$46.79B
$15.51B
$8.90B
$37.89B
$27.46B
$19.33B
$436.33M
$19.76B
$19.76B
$15.51B
$15.51B
$15.51B
$15.51B
$19.33B
$22.66B
4.44B
4.45B
$3.49
$3.49
Balance Sheet Financials
$26.11B
$31.55B
$56.09B
$82.20B
$32.65B
$18.01B
$20.17B
$52.82B
$29.38B
$9.69B
$29.38B
4.46B
Cash Flow Statement Financials
$18.03B
$-11.98B
$-4.30B
$2.37B
$4.01B
$1.64B
$217.26M
$-7.84B
--
Fundamental Metrics & Ratios
0.80
--
--
0.38
0.67
80.98%
41.30%
41.30%
48.42%
42.24%
33.14%
$8.93B
--
--
--
0.57
1.18
3.47
105.33
52.79%
160.07%
18.87%
32.73%
$6.58
$2.01
$4.05